Vanguard Group’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $6.92M | Sell |
|
|||||
|
2024
Q4 | $6.27M | Sell |
|
|||||
|
2024
Q3 | $6.42M | Buy |
|
|||||
|
2024
Q2 | $7.23M | Buy |
|
|||||
|
2024
Q1 | $2.13M | Buy |
|
|||||
|
2023
Q4 | $367K | Buy |
|
|||||
|
2023
Q3 | $391K | Buy |
|
|||||
|
2023
Q2 | $416K | Hold |
|
|||||
|
2023
Q1 | $240K | Hold |
|
|||||
|
2022
Q4 | $387K | Buy |
|
|||||
|
2022
Q3 | $480K | Sell |
|
|||||
|
2022
Q2 | $772K | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $955K | Sell |
|
|||||
|
2021
Q3 | $2.15M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Sell |
|
|||||
|
2021
Q1 | $5.03M | Buy |
|
|||||
|
2020
Q4 | $522K | Buy |
|
|||||
|
2020
Q3 | $54K | Buy |
|
|||||
|
2020
Q2 | $22K | Hold |
|
|||||
|
2020
Q1 | $15K | Hold |
|
|||||
|
2019
Q4 | $29K | Hold |
|
|||||
|
2019
Q3 | $23K | Hold |
|
|||||
|
2019
Q2 | $41K | Sell |
|
|||||
|
2019
Q1 | $44K | Sell |
|
|||||
|
2018
Q4 | $210K | Buy |
|
|||||
|
2018
Q3 | $517K | Sell |
|
|||||
|
2018
Q2 | $1.75M | Sell |
|
|||||
|
2018
Q1 | $2M | Buy |
|
|||||
|
2017
Q4 | $2.56M | Sell |
|
|||||
|
2017
Q3 | $3.59M | Buy |
|
|||||
|
2017
Q2 | $1.45M | Sell |
|
|||||
|
2017
Q1 | $2.52M | Buy |
|
|||||
|
2016
Q4 | $1.53M | Sell |
|
|||||
|
2016
Q3 | $4.41M | Buy |
|
|||||
|
2016
Q2 | $3.69M | Buy |
|
|||||
|
2016
Q1 | $8.15M | Buy |
|
|||||
|
2015
Q4 | $9.63M | Buy |
|
|||||
|
2015
Q3 | $6.69M | Buy |
|
|||||
|
2015
Q2 | $9.89M | Buy |
|
|||||
|
2015
Q1 | $14.3M | Buy |
|
|||||
|
2014
Q4 | $12.2M | Buy |
|
|||||
|
2014
Q3 | $3.23M | Buy |
|
|||||
|
2014
Q2 | $3.63M | Buy |
|
|||||
|
2014
Q1 | $3.78M | Buy |
|
|||||
|
2013
Q4 | $1.8M | Buy |
|
|||||
|
2013
Q3 | $2.15M | Buy |
|
|||||
|
2013
Q2 | $712K | Buy |
|